Invention Grant
- Patent Title: Polymalic acid-based multi-functional drug delivery system
- Patent Title (中): 聚马来酸多功能药物输送系统
-
Application No.: US10580999Application Date: 2004-12-03
-
Publication No.: US07935677B2Publication Date: 2011-05-03
- Inventor: Julia Y. Ljubimova , Keith L. Black , Eggehard Holler
- Applicant: Julia Y. Ljubimova , Keith L. Black , Eggehard Holler
- Applicant Address: US CA Los Angeles
- Assignee: Cedars-Sinai Medical Center
- Current Assignee: Cedars-Sinai Medical Center
- Current Assignee Address: US CA Los Angeles
- Agency: Lawson & Weitzen, LLP
- Agent Sonia K. Guteman; Marina Sigareva
- International Application: PCT/US2004/040660 WO 20041203
- International Announcement: WO2005/155980 WO 20050623
- Main IPC: C12N15/11
- IPC: C12N15/11 ; A61K47/30 ; A61K9/00

Abstract:
A structured drug system that is useful for delivering a drug payload to a specific tissue or cell type is disclosed. The system is based on purified polymalic acid. This polymer isolated from natural sources is biocompatible, biodegradable and of very low toxicity. The polymer is extremely water soluble and contains a large number of free carboxyl groups which can used to attach a number of different active molecules. In the examples disclosed N-hydroxysuccinimide esters of the carboxyl groups are used to attach such molecules. The active molecules include monoclonal antibodies to promote specific cellular uptake and specific pro-drugs such as antisense nucleic acids designed to modify the cellular metabolism of a target cell. The pro-drugs are advantageously linked by a somewhat labile bond so that they will be released under specific conditions. In addition, the system contains amide-linked valine to encourage membrane disruption under lysosomal conditions. Polyethylene glycol groups are attached to extend the drug system's circulation half-life. In addition, fluorescent reported groups can be readily included to aid in visualizing and confirming drug system targeting. The drug system can deliver treatments for a wide range of diseases and is specially advantageous for treatment of neoplasms.
Public/Granted literature
- US20070259008A1 Polymalic Acid-Based Multi-Functional Drug Delivery System Public/Granted day:2007-11-08
Information query
IPC分类: